US20020127285A1 - Rhodiola and uses thereof - Google Patents
Rhodiola and uses thereof Download PDFInfo
- Publication number
- US20020127285A1 US20020127285A1 US10/139,383 US13938302A US2002127285A1 US 20020127285 A1 US20020127285 A1 US 20020127285A1 US 13938302 A US13938302 A US 13938302A US 2002127285 A1 US2002127285 A1 US 2002127285A1
- Authority
- US
- United States
- Prior art keywords
- rhodiola
- levels
- effective amount
- subject
- crenulata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
Definitions
- the present invention relates to compositions, articles of manufacture, extracts, compounds, methods of use, methods of treatment, methods of preparation, etc., which relate to plants of the genus Rhodiola, preferably Rhodiola crenulata , which have a variety of useful and beneficial effects, including, e.g., to enhance blood oxygen and nutrients levels, e.g., through enhancing oxygen transport, to enhance working capacity and endurance, to reduce muscle fatigue, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to protect against oxidation, to provide anti-cancer effects, to promote DNA repair, to provide anti-radiation effects, to protect against radiation, to reduce inflammation, to increase insulin, to decrease levels of glucagon, to reduce histamine release, to reduce allergic reactions, preferably, to modulate testosterone levels, and to modulate sleep, especially to promote sleep, to modulate blood lipids, preferably, e.g., to lower cholesterol levels, to promote weight loss, and to enhance sexuability,
- Rhodiola crenulata is a species of Rhodiola which grows mostly in China and south west of China on the altitude between 3400 meters to 5600 meters. It has been used in Vietnamese medicine for more than 1000 years for uses that have been limited to curing lung inflammation and cough, for stopping and activating blood, and for treating external wounds and burns. It has been discovered herein that Rhodiola crenulata has other beneficial properties that make it useful for a variety of conditions and diseases, as mentioned above and below.
- Rhodiola is a diverse genus of plants which includes more than 50 different species, including, e.g., algida, arctica, crenulata, elongata, gelida, imbricataishidae, iremelica, kirilowii, linearifolia, phariensis, pinnatifida, quadrifida, aff. quadrifida, rosea, sachalinensis, and wolongensis.
- chromosome number e.g., Makoto et al., Journal of Japanese Botany, 70(6):334-338, 1995
- chemical composition e.g., Makoto et al., Journal of Japanese Botany, 70(6):334-338, 1995
- chemical composition e.g., Makoto et al., Journal of Japanese Botany, 70(6):334-338, 1995
- chemical composition e.g., Makoto et al., Journal of Japanese Botany, 70(6):334-338, 1995
- chemical composition e.g., morphology, medicinal properties, developmental stages (e.g., Ishmuratatova and Satsyperova, Rasembl'nye Resursy., 34(1):3-11, 1998), geographical distribution, etc.
- Scientific studies e.g.
- Rhodiola crenulata include, e.g., salidroside, tyrosol, ⁇ -sitosterol, gallic acid, pyrogallol, crenulatin, rhodionin, rhodiosin, among which, crenulatin, e.g., is found only in R. crenulata and has not been found in any other Rhodiola species.
- Rhodiosin and rhodionin exists in some, but not all, Rhodiola species.
- plant refers to seeds, leaves, stems, flowers, roots, berries, bark, or any other plant parts that are useful for the purposes described.
- the underground portion of the plant such as the root and rhizoma
- the leaves, stems, seeds, flowers, berries, bark, or other plant parts also have medicinal effects and can be used for preparing tea and other beverages, cream, and in food preparation.
- Rhodiola of the present invention can be in any form which is effective, including, but not limited to dry powders, grounds, emulsions, extracts, and other conventional compositions.
- a suitable solvent such as water, alcohol, methanol, or any other solvents, or mixed solvents.
- the choice of the solvent can be made routinely, e.g., based on the properties of the active ingredient that is to be extracted or concentrated by the solvent.
- Rhodiola crenulata examples include, but are not limited to, salidroside, tyrosol, ⁇ -sitosterol, gallic acid, pyrogallol, crenulatin, rhodionin, and/or rhodiosin. These ingredients can be extracted in the same step, e.g., using an alcoholic solvent, or they may be extracted individually, each time using a solvent which is especially effective for extracting the particular target ingredient from the plant. In certain embodiments, extraction can be performed by the following process: Milling the selected part, preferably root, to powder. The powder can be soaked in a desired solvent for an amount of time effective to extract the active agents from the Rhodiola.
- the solution can be filtered and concentrated to produce a paste that contains a high concentration of the constituents extracted by the solvent.
- the paste can be dried to produce a powder extract of Rhodiola crenulata .
- the content of active ingredient in the extract can be measured using HPLC, UV and other spectrometry methods.
- Rhodiola of the present invention can be administered in any form by any effective route, including, e.g., oral, parenteral, enteral, intraperitoneal, topical, transdermal (e.g., using any standard patch), ophthalmic, nasally, local, non-oral, such as aerosal, inhalation, subcutaneous, intramuscular, buccal, sublingual, rectal, vaginal, intraarterial, and intrathecal, etc. It can be administered alone, or in combination with any ingredient(s), active or inactive, including in a medicinal form, or as a food or beverage additive.
- any effective route including, e.g., oral, parenteral, enteral, intraperitoneal, topical, transdermal (e.g., using any standard patch), ophthalmic, nasally, local, non-oral, such as aerosal, inhalation, subcutaneous, intramuscular, buccal, sublingual, rectal, vaginal, intraarterial, and intrathecal, etc. It can be administered
- Rhodiola is administered orally in any suitable form, including, e.g., whole plant, powdered or pulverized plant material, extract, pill, capsule, granule, tablet or a suspension.
- Rhodiola can be combined with any pharmaceutically acceptable carrier.
- pharmaceutically acceptable carriers any pharmaceutical carrier, such as the standard carriers described, e.g., Remington 's Pharmaceutical Science , Eighteenth Edition, Mack Publishing company, 1990.
- suitable carriers are well known in the art and can include, but are not limited to, any of the standard pharmaceutical carriers such as a phosphate buffered saline solutions, phosphate buffered saline containing Polysorb 80, water, emulsions such as oil/water emulsion and various type of wetting agents.
- Other carriers may also include sterile solutions, tablets, coated tablets pharmaceutical and capsules.
- Such carriers typically contain excipients such as starch, milk, sugar, certain types of clay, gelatin, stearic acid or salts thereof, magnesium or calcium stearate, talc, vegetable fats or oils, gums, glycols.
- excipients such as starch, milk, sugar, certain types of clay, gelatin, stearic acid or salts thereof, magnesium or calcium stearate, talc, vegetable fats or oils, gums, glycols.
- Such carriers can also include flavor and color additives or other ingredients.
- Compositions comprising such carriers are formulated by well known conventional methods.
- excipients formulated with Rhodiola are suitable for oral administration and do not deleteriously react with it, or other active components.
- Suitable pharmaceutically acceptable carriers include but are not limited to water, salt solutions, alcohols, gum arabic, vegetable oils, benzyl alcohols, gelatin, carbohydrates such as lactose, amylose or starch, magnesium stearate, talc, silicic acid, viscous paraffin, perfume oil, fatty acid monoglycerides and diglycerides, pentaerythritol fatty acid esters, hydroxy methylcellulose and the like.
- additives include, e.g., antioxidants and preservatives, coloring, flavoring and diluting agents, emulsifying and suspending agents, such as acacia, agar, alginic acid, sodium alginate, bentonite, carbomer, carrageenan, carboxymethylcellulose, cellulose, cholesterol, gelatin, hydroxyethyl cellulose, hydroxppropyl cellulose, hydroxypropyl methylcellulose, methylcellulose, octoxynol 9, oleyl alcohol, povidone, propylene glycol monostearate, sodium lauryl sulfate, sorbitan esters, stearyl alcohol, tragacanth, xanthan gum, and derivatives thereof, solvents, and miscellaneous ingredients such as microcrystalline cellulose, citric acid, dextrin, dextrose, liquid glucose, lactic acid, lactose, magnesium chloride, potassium metaphosphate, starch, and the like.
- Rhodiola can also be formulated with other active ingredients, such as anti-oxidants, vitamins (A, C, ascorbic acid, B's, such as B1, thiamine, B6, pyridoxine, B complex, biotin, choline, nicotinic acid, pantothenic acid, B12, cyanocobalamin, and/or B2, D, D2, D3, calciferol, E, such as tocopherol, riboflavin, K, K1, K2).
- vitamins A, C, ascorbic acid, B's, such as B1, thiamine, B6, pyridoxine, B complex, biotin, choline, nicotinic acid, pantothenic acid, B12, cyanocobalamin, and/or B2, D, D2, D3, calciferol, E, such as tocopherol, riboflavin, K, K1, K2).
- vitamins A, C, ascorbic acid, B's, such as B1, thiamine,
- Preferred compounds include, e.g creatine monohydrate, pyruvate, L-Camitine, ⁇ -lipoic acid, Phytin or Phytic acid, Co Enzyme Q10, NADH, NAD, D-ribose, amino acids such as L-Glutamine, Lysine, chrysin; pre-hormones such as 4-drostenedione, 5-androstenedione, 4(or 5-)androstenediol, 19-nor-4 (or 5-)-drostenedione, 19-nor-4 (or 5-)-androstenediol, Beta-ecdysterone, and 5-Methyl-7-Methoxy Isoflavone.
- pre-hormones such as 4-drostenedione, 5-androstenedione, 4(or 5-)androstenediol, 19-nor-4 (or 5-)-drostenedione, 19-nor-4 (or 5-)-androstenediol
- Preferred active ingredients include, e.g., pine pollen, fructus lycii, hippophae rhamnoides, Salvia Miltiorrhiza, Ligusticum, Acanthopanax, Astragalus, Ephedra, codonopsis, polygola tenuifolia Willd, Lilium, Sparganium, ginseng, panax notogiseng, Garcinia, Guggle, Grape Seed Extract or powder, and/or Ginkgo Biloba.
- Rhodiola of the present invention includes those mentioned in various text and publications, e.g., ES Avensu, Medicinal Plants of West Africa , Reference Publications, Algonac, Mich. (1978); P. Back, The Illustrated Herbal 1987, Hamlyn Publishers, distributed by Octopus Books, Printed in Hong Kong by Mandarin, ISBN 0-600 553 361; F. Bianchini and F. Corbetta, The Fruits of the Earth, translated from Italian by A. Mancinelli, Bloomsbury Books, London, ISBN 1-870630-10-6; H. M. Burkill, The Useful plants of West Tropical Africa , Ed. 2, V.
- Other active agents include, e.g., antioxidants, anti-carcinogens, anti-inflammatory agents, hormones and hormone antagonists, antibiotics (e.g., amoxicillin) and other bacterial agents, and other medically useful drugs such as those identified in, e.g., Remington's Pharmaceutical Sciences , Eighteenth Edition, Mack Publishing Company, 1990.
- a preferred composition of the present invention comprises, about 1%-100%, preferably about 20-70% Rhodiola crenulata extract, more preferably about 60%, said extract having about 0.5-10% salidroside content; 10-45% 5:1 extracted fructus lycii powder (5 kilograms of the herb is used to produce 1 kg of herb powder); 1-20% of hippophae rhamnoides powder; and, optionally, a pharmaceutically-acceptable excipient.
- the present invention relates to methods of administering Rhodiola, especially Rhodiola crenulata , e.g., to enhance blood oxygen levels, to enhance working capacity and endurance, to reduce muscle fatigue, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to improve sexual ability, to provide antioxidant effects, to protect against oxidation, to provide anti-cancer effects, to promote DNA repair, to provide anti-radiation effects, to protect against radiation, to reduce inflammation, to increase insulin, to decrease levels of glucagon, to reduce histamine release, to reduce allergic reactions, preferably, to modulate testosterone levels, to increase male virality, to modulate sleep, especially to promote sleep. to modulate blood lipids, preferably, e.g., to lower cholesterol levels, to promote weight loss, to increase estradiol levels, etc., and other conditions and diseases as mentioned above and below.
- Rhodiola is delivered to the host in such a manner that it can achieve the desired purpose.
- Rhodiola can be administered by an effective route, such as orally, topically, rectally, etc.
- Rhodiola can be administered to any host in need of treatment, e.g., vertebrates, such as mammals, including humans, male humans, female humans, primates, pets, such as cats and dogs, livestock, such as cows, horses, birds, chickens, etc.
- Rhodiola is administered to such a host.
- Effective amounts are such amounts which are useful to achieve the desired effect, preferably a beneficial or therapeutic effect as described above.
- Such amount can be determined routinely, e.g., by performing a dose-response experiment in which varying doses are administered to cells, tissues, animal models (such as rats or mice in maze-testing, swimming tests, toxicity tests, memory tests as performed by standard psychological testing, etc.) to determine an effective amount in achieving an effect.
- Amounts are selected based on various factors, including the milieu to which the virus is administered (e.g., a patient with cancer, animal model, tissue culture cells, etc.), the site of the cells to be treated, the age, health, gender, and weight of a patient or animal to be treated, etc.
- Useful amounts include, 10 milligrams-100 grams, preferably, e.g., 100 milligrams-10 grams, 250 milligrams-2.5 grams, 1 gm, 2 gm, 3 gm, 500 milligrams-1.25 grams. etc., per dosage of different forms of Rhodiola crenulata such as the herbal powder, herbal extract paste or powder, tea and beverages prepared to contain the effective ingredients of Rhodiola, injections, depending upon the need of the recipients and the method of preparation.
- the present invention relates to a method of increasing testosterone levels in a host in need thereof, comprising, administering an effective amount of a Rhodiola to said host.
- Testosterone principal male hormone, or androgen
- Testosterone is produced mainly in the Leydig cells in the male testes.
- the Leydig cells also produce two other androgens of less potency and in much smaller quantities.
- Testosterone stimulates the development of the male secondary sex characteristics after puberty, causing growth of the beard and pubic hair, development of the penis, and change of voice.
- the hormone also aids in growth, muscular development, and masculine body contour of the adult male.
- Testosterone is considered to be a male virilizing hormone. Its effects include maintenance of muscle and bone mass, improving and/or enhancing sexual function and psychological well being among others. As males grow older, especially after the age of 35, a slow decline in testosterone levels is observed which is accompanied by symptoms that have been associated with the condition known as “andropause”. Symptoms of andropause include lethargy, depression, lack of sexual desire and function, and loss of muscle mass and strength. Increasing testosterone levels therefore can be useful to treat any of the mentioned conditions. Additionally, increasing testosterone levels can be useful in treating certain types of breast cancer in women.
- Testosterone levels refer to the amounts of testosterone which are circulating in the blood, e.g., as measured using enzyme-linked immunosorbent assay, HPLC, or any other suitable detection method.
- Rhodiola crenulata Any effective amount of Rhodiola crenulata can be administered.
- a standardized Rhodiola crenulata extract e.g., having 0.1-110%. preferably 1-6%) salidroside by total weight of composition
- intake of a standardized Rhodiola crenulata extract e.g., having 0.1-110%. preferably 1-6%) salidroside by total weight of composition
- a standardized Rhodiola crenulata extract e.g., having 0.1-110%. preferably 1-6%) salidroside by total weight of composition
- subjects showed about a 76% increase in total testosterone in the blood as compared to the 6.0% increase in total testosterone level after taking placebo for a month.
- These amounts can be increased by any value, e.g., at least about 5%, 10%, 15%, 20%, 50%, 60% 70%, 75%, 100%, 2-fold, 5-fold, etc., over amounts which are present in the blood prior to
- the present invention also relates to a method of increasing estradiol levels in a host in need thereof, comprising, administering an effective amount of a Rhodiola to said host.
- Estradiol is a female sex hormone that stimulates the appearance of secondary female sex characteristics in girls at puberty. Estradiol controls growth of the lining of the uterus during the first part of the menstrual cycle, cause changes in the breast during pregnancy, and regulate various metabolic processes. Increasing estradiol can treat various conditions, including menopausal symptoms, estrogen deficiencies in women (most commonly after menopause; low eight; etc) and inflammation of the vagina. It can also stimulate lactation following childbirth and in the treatment, but not cure, advanced and even disseminated cancer of the prostate gland in men.
- Amounts of estradiol can be increased by any value, e.g., 5%, 6%, 8%, 10%, 15%, 20%, 30%, 50%, 75%, 100%, 2-fold, 5-fold, etc., over amounts which are present in the blood prior to administration.
- Rhodiola as effective in increasing estradiol levels by about 12% as compared to only 3% in controls.
- Rhodiola can used to treat conditions associated with estrogen deficiency, such as menopuse, perimenopause, low-weight, etc.
- Rhodiola can be combined with any agent which raises testosterone and/or estradiol levels.
- testosterone precursors such as those disclosed in U.S. Pat. Nos. 5,880,117 and 6,011,027, e.g., 4-androstenediol and 19-nor-4-androstenediol, can be utilized in combination with Rhodiola as a means of increasing testosterone levels in human.
- Rhodiola crenulata can also be formulated to boost hormonal levels with other herbs, such as wild yam, Epimedium (including all Epimedium species), Angelica, Lycium, panex ginseng, Ganoderma lucidum , Codonopsis, Eleutherococcus, Schisandra chinensis , Atractylodes, and Ligustrum lucidum.
- other herbs such as wild yam, Epimedium (including all Epimedium species), Angelica, Lycium, panex ginseng, Ganoderma lucidum , Codonopsis, Eleutherococcus, Schisandra chinensis , Atractylodes, and Ligustrum lucidum.
- the present invention also relates methods of improving sleep in a host in need thereof, comprising administering an effective amount of a Rhodiola to said host.
- a beneficial effect on sleep including, e.g., prolonging sleep time (e.g., as measured in animal models by administering Rhodiola in the presence or absence of a barbiturate, or other sleep-promoting agent, and determining the sleep-prolongation time produced by Rhodiola), increasing time spent in REM-sleep, reducing sleep apnea and other sleep disorders, decreasing insomnia, decreasing amount of time to fall asleep, etc.
- Rhodiola can also be formulated with other agents which promote sleep, such as Valerian, Melatonin, Kava Kava, St. John's Wort, Tryptophan and 5-Hydroxytryptophan, Astragalus, Hops, Passionflower, Skullcap, Chamomile, He Shou Wu, Ashwaganda, and Lady's Slipper.
- agents which promote sleep such as Valerian, Melatonin, Kava Kava, St. John's Wort, Tryptophan and 5-Hydroxytryptophan, Astragalus, Hops, Passionflower, Skullcap, Chamomile, He Shou Wu, Ashwaganda, and Lady's Slipper.
- the present invention also relates to methods of treating impotence, comprising administering an effective amount of Rhodiola, preferable Rhodiola crenulata .
- Impotency, or erectile dysfunction is the inability to achieve an erection.
- the ability of Rhodiola crenulata to increase the blood oxygen transportation and testosterone level can enhance male sexual ability and performance in some cases.
- the Rhodiola can be administered immediately prior to performance, or more preferably, on a daily basis according to the regime mentioned above to increase testosterone levels.
- Rhodiola can also be administered in combination with agents which are used for treating impotency, including, e.g., vasodilators, phosphodiesterase inhibitors, stimulators of NO release, alpha-adrenergic agents, etc.
- Rhodiola crenulata can also be used to enhance blood oxygen levels and transport to body tissues; to enhance working capacity and endurance.
- working capacity and endurance it preferably meant that the effective amount increases the ability to perform a physical task, such as in exercise, physical labor, or sports activity, even before fatigue would normally occur; thus, enhanced working capacity and endurance is defined herein not to mean “fatigue,” which simply indicates that the performer does not tire.
- Associated with enhanced working capacity and endurance can be an increase in muscle ATP levels and a reduction in circulating lactic acid levels (see, Examples 2 and 3).
- the present invention also relates to methods of increasing muscle ATP levels and/or reducing lactic acid in blood, thereby enhancing working capacity and endurance, improving sexual performance, etc.
- Rhodiola crenulata reduces blood lactic acid (lactate) levels. Such reduction in lactic acid levels indicates that muscle fatigue is reduced.
- muscle fatigue it is meant that the muscle cells carry out anaerobic respiration because of lack of oxygen. Reducing muscle fatigue therefore means, e.g., that fewer muscle cells become anaerobic.
- the present invention therefore also relates to a method of reducing muscle fatigue comprising administering an effective amount of Rhodiola crenulata . Lactic acid can be reduced by an effective amount in ameliorating fatigue, such as at least 10%, 15%, 20 %, 25 %, 30 %, 35 %, etc.
- Rhodiola crenulata increases the ATP available to muscle, e.g., by increasing aerobic respiration, by increasing oxygen transport, etc. Amounts of ATP can be increased by an effective amount in reducing muscle fatigue, such as 20%, 25%, 30%, 35%, 37%, 40%, 40%, 45%, 50%, etc.
- Rhodiola can also be used to enhance or improved memory and concentration (such improved functions are to be distinguished from the more general brain stimulation which indicates increased non-selective neuronal activity, whereas the mentioned improved functions are selective, e.g., by stimulating specific parts of the brain or other organs, or by stimulating specific neural and hormonal systems); to reduce stress, e.g., lower blood pressure, reduce anxiety, promote calmness; to enhance cardiac and cardiovascular function (including, e.g., to protect against heart disease); to provide antioxidant effects and protect against oxidation; to provide anti-cancer effects, e.g., promote cessation of cell growth; to promote DNA repair; to provide anti-radiation effects and to protect against radiation, e.g., as a sun-screen when applied topically to the skin; to reduce inflammation, e.g., systemic inflammation, skin inflammation (where Rhodiola can be administered topically), but with the proviso that it is not lung-inflammation, coughing, or bleeding associated with lung-inflammation and coughing
- mice 10 males and 10 females, weighing approximately 18-22 grams each, were randomly divided into experimental and control groups, with each group containing 10 mice.
- Mice in the experimental group were provided with food containing about 50 mg (0.05 gram, about 0.25 gram every 1 kilogram body weight) Rhodiola crenulata per day for 3 days.
- Mice in the control group were fed with the same food but without Rhodiola crenulata.
- mice After 3 days of consuming food containing Rhodiola crenulata , the mice were subjected to a swimming test. A lead weight that comprised about 6% of the mice's body weight was attached to each mouse prior to placing it in a water-filled receptacle. The average survival time for experimental group was 92.85 ⁇ 5.20 minutes while for the control group it was 69.89 ⁇ 5.10 minutes. This represents a 33% improvement in the endurance of mice fed Rhodiola crenulata as compared to controls.
- test groups 40 volunteers are divided into two groups, each comprising 20 people.
- the test group was administered 2 grams of Rhodiola crenulata standardized extract (with 2% salidroside), once a day for one month.
- the control group received a placebo. After one month, each participant was required to assess improvement of their memory, sleep, physical strength, and sexual performance. Blood samples were collected prior to taking any Rhodiola and after the one-month period.
- test subjects were asked whether their memory was improved during the course of the test. In the test group, 45% stated that their memory was improved after one month of the medication. In the control group, only 21% reported memory improvement after one month of the placebo.
- test subjects were asked whether their physical strength was improved. In the test group, 81% reported improvements in physical strength after one month of the medication as compared to only 38% in the control group.
- Test subjects were asked whether their sexual performance was improved. In the test group, 75% described improved sexual performance after one month of the Rhodiola extract. In the control group, only 28.9% said their sexual performance was improved.
- Test subjects were asked whether their sleep is improved. In the test group, 83% of the subjects their sleep was improved after one month of the Rhodiola. In the control group, 41% said their sleep is improved after one month medication.
- the blood testosterone levels of each participant was tested.
- the average of testosterone level of the test group before and after taking Rhodiola crenulata , once a day, for a month was 17.68 ⁇ 5.6 mmol/L and 31.12 ⁇ 10.6 mmol/L, respectively.
- the average testosterone level before and after taking placebo for a month was 18.02 ⁇ 6.0 mmol/L and 19.10 ⁇ 7.6 mmol/L respectively.
- the Rhodiola increased testosterone levels by 76%, while in controls the increase was only 6%.
- a composition comprising effective amounts of Rhodiola crenulata can be administered to subjects to enhance levels of blood oxygen, to enhance working capacity and endurance, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to modulate testosterone levels, to modulate sleep, and to improve sexual performance. to increase energy level, and to enhance memory and concentration.
- a composition can comprise, by weight:
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Rhodiola, preferably Rhodiola crenulata, to treat various conditions and diseases in mammals. Rhodiola crenulata is a Tibetan herb which has been discovered to have highly useful and beneficial properties heretofore unknown. Rhodiola crenulata is especially preferred to enhance blood oxygen levels, to enhance working capacity and endurance, to enhance memory and concentration, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to protect against oxidation, to modulate testosterone and estradiol levels, to modulate sleep, and to enhance sexuability, such as improve sexual performance.
Description
- The present invention relates to compositions, articles of manufacture, extracts, compounds, methods of use, methods of treatment, methods of preparation, etc., which relate to plants of the genus Rhodiola, preferably Rhodiola crenulata, which have a variety of useful and beneficial effects, including, e.g., to enhance blood oxygen and nutrients levels, e.g., through enhancing oxygen transport, to enhance working capacity and endurance, to reduce muscle fatigue, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to protect against oxidation, to provide anti-cancer effects, to promote DNA repair, to provide anti-radiation effects, to protect against radiation, to reduce inflammation, to increase insulin, to decrease levels of glucagon, to reduce histamine release, to reduce allergic reactions, preferably, to modulate testosterone levels, and to modulate sleep, especially to promote sleep, to modulate blood lipids, preferably, e.g., to lower cholesterol levels, to promote weight loss, and to enhance sexuability, such as improve sexual performance.
- Rhodiola crenulata is a species of Rhodiola which grows mostly in Tibet and south west of China on the altitude between 3400 meters to 5600 meters. It has been used in Tibetan medicine for more than 1000 years for uses that have been limited to curing lung inflammation and cough, for stopping and activating blood, and for treating external wounds and burns. It has been discovered herein that Rhodiola crenulata has other beneficial properties that make it useful for a variety of conditions and diseases, as mentioned above and below.
- Rhodiola is a diverse genus of plants which includes more than 50 different species, including, e.g., algida, arctica, crenulata, elongata, gelida, imbricataishidae, iremelica, kirilowii, linearifolia, phariensis, pinnatifida, quadrifida, aff. quadrifida, rosea, sachalinensis, and wolongensis. These species vary from each other widely, differing in, e.g., chromosome number (e.g., Makoto et al., Journal of Japanese Botany, 70(6):334-338, 1995), chemical composition, morphology, medicinal properties, developmental stages (e.g., Ishmuratatova and Satsyperova, Rastitel'nye Resursy., 34(1):3-11, 1998), geographical distribution, etc. Scientific studies (e.g. Peng et al, Chinese Herb Medicine(1995), 26(4): 177-179, and Wang et al, Acta Phrmaceutica Sinica(1992), 27(2): 117-120) indicate constituents of Rhodiola crenulata include, e.g., salidroside, tyrosol, β-sitosterol, gallic acid, pyrogallol, crenulatin, rhodionin, rhodiosin, among which, crenulatin, e.g., is found only in R. crenulata and has not been found in any other Rhodiola species. Rhodiosin and rhodionin exists in some, but not all, Rhodiola species.
- The term “plant” as used herein refers to seeds, leaves, stems, flowers, roots, berries, bark, or any other plant parts that are useful for the purposes described. For certain uses, it is preferred that the underground portion of the plant, such as the root and rhizoma, be utilized. The leaves, stems, seeds, flowers, berries, bark, or other plant parts, also have medicinal effects and can be used for preparing tea and other beverages, cream, and in food preparation.
- Rhodiola of the present invention can be in any form which is effective, including, but not limited to dry powders, grounds, emulsions, extracts, and other conventional compositions. To extract or concentrate the effective ingredients of Rhodiola, typically the plant part is contacted with a suitable solvent, such as water, alcohol, methanol, or any other solvents, or mixed solvents. The choice of the solvent can be made routinely, e.g., based on the properties of the active ingredient that is to be extracted or concentrated by the solvent. Preferred active ingredients of Rhodiola crenulata include, but are not limited to, salidroside, tyrosol, β-sitosterol, gallic acid, pyrogallol, crenulatin, rhodionin, and/or rhodiosin. These ingredients can be extracted in the same step, e.g., using an alcoholic solvent, or they may be extracted individually, each time using a solvent which is especially effective for extracting the particular target ingredient from the plant. In certain embodiments, extraction can be performed by the following process: Milling the selected part, preferably root, to powder. The powder can be soaked in a desired solvent for an amount of time effective to extract the active agents from the Rhodiola. The solution can be filtered and concentrated to produce a paste that contains a high concentration of the constituents extracted by the solvent. In some cases, the paste can be dried to produce a powder extract of Rhodiola crenulata. The content of active ingredient in the extract can be measured using HPLC, UV and other spectrometry methods.
- A Rhodiola of the present invention can be administered in any form by any effective route, including, e.g., oral, parenteral, enteral, intraperitoneal, topical, transdermal (e.g., using any standard patch), ophthalmic, nasally, local, non-oral, such as aerosal, inhalation, subcutaneous, intramuscular, buccal, sublingual, rectal, vaginal, intraarterial, and intrathecal, etc. It can be administered alone, or in combination with any ingredient(s), active or inactive, including in a medicinal form, or as a food or beverage additive.
- In preferred embodiments of the invention, Rhodiola is administered orally in any suitable form, including, e.g., whole plant, powdered or pulverized plant material, extract, pill, capsule, granule, tablet or a suspension.
- Rhodiola can be combined with any pharmaceutically acceptable carrier. By the phrase, “pharmaceutically acceptable carriers,” it is meant any pharmaceutical carrier, such as the standard carriers described, e.g., Remington 's Pharmaceutical Science, Eighteenth Edition, Mack Publishing company, 1990. Examples of suitable carriers are well known in the art and can include, but are not limited to, any of the standard pharmaceutical carriers such as a phosphate buffered saline solutions, phosphate buffered saline containing Polysorb 80, water, emulsions such as oil/water emulsion and various type of wetting agents. Other carriers may also include sterile solutions, tablets, coated tablets pharmaceutical and capsules. Typically such carriers contain excipients such as such as starch, milk, sugar, certain types of clay, gelatin, stearic acid or salts thereof, magnesium or calcium stearate, talc, vegetable fats or oils, gums, glycols. Such carriers can also include flavor and color additives or other ingredients. Compositions comprising such carriers are formulated by well known conventional methods. Generally excipients formulated with Rhodiola are suitable for oral administration and do not deleteriously react with it, or other active components.
- Suitable pharmaceutically acceptable carriers include but are not limited to water, salt solutions, alcohols, gum arabic, vegetable oils, benzyl alcohols, gelatin, carbohydrates such as lactose, amylose or starch, magnesium stearate, talc, silicic acid, viscous paraffin, perfume oil, fatty acid monoglycerides and diglycerides, pentaerythritol fatty acid esters, hydroxy methylcellulose and the like. Other additives include, e.g., antioxidants and preservatives, coloring, flavoring and diluting agents, emulsifying and suspending agents, such as acacia, agar, alginic acid, sodium alginate, bentonite, carbomer, carrageenan, carboxymethylcellulose, cellulose, cholesterol, gelatin, hydroxyethyl cellulose, hydroxppropyl cellulose, hydroxypropyl methylcellulose, methylcellulose, octoxynol 9, oleyl alcohol, povidone, propylene glycol monostearate, sodium lauryl sulfate, sorbitan esters, stearyl alcohol, tragacanth, xanthan gum, and derivatives thereof, solvents, and miscellaneous ingredients such as microcrystalline cellulose, citric acid, dextrin, dextrose, liquid glucose, lactic acid, lactose, magnesium chloride, potassium metaphosphate, starch, and the like.
- Rhodiola can also be formulated with other active ingredients, such as anti-oxidants, vitamins (A, C, ascorbic acid, B's, such as B1, thiamine, B6, pyridoxine, B complex, biotin, choline, nicotinic acid, pantothenic acid, B12, cyanocobalamin, and/or B2, D, D2, D3, calciferol, E, such as tocopherol, riboflavin, K, K1, K2). Preferred compounds, include, e.g creatine monohydrate, pyruvate, L-Camitine, α-lipoic acid, Phytin or Phytic acid, Co Enzyme Q10, NADH, NAD, D-ribose, amino acids such as L-Glutamine, Lysine, chrysin; pre-hormones such as 4-drostenedione, 5-androstenedione, 4(or 5-)androstenediol, 19-nor-4 (or 5-)-drostenedione, 19-nor-4 (or 5-)-androstenediol, Beta-ecdysterone, and 5-Methyl-7-Methoxy Isoflavone. Preferred active ingredients include, e.g., pine pollen, fructus lycii, hippophae rhamnoides, Salvia Miltiorrhiza, Ligusticum, Acanthopanax, Astragalus, Ephedra, codonopsis, polygola tenuifolia Willd, Lilium, Sparganium, ginseng, panax notogiseng, Garcinia, Guggle, Grape Seed Extract or powder, and/or Ginkgo Biloba.
- Other plants and herbs which can be formulated with a Rhodiola of the present invention includes those mentioned in various text and publications, e.g., ES Avensu, Medicinal Plants of West Africa, Reference Publications, Algonac, Mich. (1978); P. Back, The Illustrated Herbal 1987, Hamlyn Publishers, distributed by Octopus Books, Printed in Hong Kong by Mandarin, ISBN 0-600 553 361; F. Bianchini and F. Corbetta, The Fruits of the Earth, translated from Italian by A. Mancinelli, Bloomsbury Books, London, ISBN 1-870630-10-6; H. M. Burkill, The Useful plants of West Tropical Africa, Ed. 2, V. I, Royal Botanic Gardens Kew, ISBN 0-947643-01-X (1985); L. Boulos, Medicinal Plants of North Africa, Reference Publications Inc., Algonac, Mich. (1983); and N. C. Shah, Herbal Folk Medicines in Northern India, J. Ethnopharm, 6:294-295 (1982).
- Other active agents include, e.g., antioxidants, anti-carcinogens, anti-inflammatory agents, hormones and hormone antagonists, antibiotics (e.g., amoxicillin) and other bacterial agents, and other medically useful drugs such as those identified in, e.g., Remington's Pharmaceutical Sciences, Eighteenth Edition, Mack Publishing Company, 1990. A preferred composition of the present invention comprises, about 1%-100%, preferably about 20-70% Rhodiola crenulata extract, more preferably about 60%, said extract having about 0.5-10% salidroside content; 10-45% 5:1 extracted fructus lycii powder (5 kilograms of the herb is used to produce 1 kg of herb powder); 1-20% of hippophae rhamnoides powder; and, optionally, a pharmaceutically-acceptable excipient.
- The present invention relates to methods of administering Rhodiola, especially Rhodiola crenulata, e.g., to enhance blood oxygen levels, to enhance working capacity and endurance, to reduce muscle fatigue, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to improve sexual ability, to provide antioxidant effects, to protect against oxidation, to provide anti-cancer effects, to promote DNA repair, to provide anti-radiation effects, to protect against radiation, to reduce inflammation, to increase insulin, to decrease levels of glucagon, to reduce histamine release, to reduce allergic reactions, preferably, to modulate testosterone levels, to increase male virality, to modulate sleep, especially to promote sleep. to modulate blood lipids, preferably, e.g., to lower cholesterol levels, to promote weight loss, to increase estradiol levels, etc., and other conditions and diseases as mentioned above and below.
- By the term “administering,” it is meant that Rhodiola is delivered to the host in such a manner that it can achieve the desired purpose. As mentioned Rhodiola can be administered by an effective route, such as orally, topically, rectally, etc. Rhodiola can be administered to any host in need of treatment, e.g., vertebrates, such as mammals, including humans, male humans, female humans, primates, pets, such as cats and dogs, livestock, such as cows, horses, birds, chickens, etc.
- An effective amount of Rhodiola is administered to such a host. Effective amounts are such amounts which are useful to achieve the desired effect, preferably a beneficial or therapeutic effect as described above. Such amount can be determined routinely, e.g., by performing a dose-response experiment in which varying doses are administered to cells, tissues, animal models (such as rats or mice in maze-testing, swimming tests, toxicity tests, memory tests as performed by standard psychological testing, etc.) to determine an effective amount in achieving an effect. Amounts are selected based on various factors, including the milieu to which the virus is administered (e.g., a patient with cancer, animal model, tissue culture cells, etc.), the site of the cells to be treated, the age, health, gender, and weight of a patient or animal to be treated, etc. Useful amounts include, 10 milligrams-100 grams, preferably, e.g., 100 milligrams-10 grams, 250 milligrams-2.5 grams, 1 gm, 2 gm, 3 gm, 500 milligrams-1.25 grams. etc., per dosage of different forms of Rhodiola crenulata such as the herbal powder, herbal extract paste or powder, tea and beverages prepared to contain the effective ingredients of Rhodiola, injections, depending upon the need of the recipients and the method of preparation.
- In preferred embodiments, the present invention relates to a method of increasing testosterone levels in a host in need thereof, comprising, administering an effective amount of a Rhodiola to said host. Testosterone, principal male hormone, or androgen, is produced mainly in the Leydig cells in the male testes. The Leydig cells also produce two other androgens of less potency and in much smaller quantities. Testosterone stimulates the development of the male secondary sex characteristics after puberty, causing growth of the beard and pubic hair, development of the penis, and change of voice. The hormone also aids in growth, muscular development, and masculine body contour of the adult male.
- Testosterone is considered to be a male virilizing hormone. Its effects include maintenance of muscle and bone mass, improving and/or enhancing sexual function and psychological well being among others. As males grow older, especially after the age of 35, a slow decline in testosterone levels is observed which is accompanied by symptoms that have been associated with the condition known as “andropause”. Symptoms of andropause include lethargy, depression, lack of sexual desire and function, and loss of muscle mass and strength. Increasing testosterone levels therefore can be useful to treat any of the mentioned conditions. Additionally, increasing testosterone levels can be useful in treating certain types of breast cancer in women.
- Testosterone levels refer to the amounts of testosterone which are circulating in the blood, e.g., as measured using enzyme-linked immunosorbent assay, HPLC, or any other suitable detection method.
- Any effective amount of Rhodiola crenulata can be administered. In accordance with present invention, it has been demonstrated that intake of a standardized Rhodiola crenulata extract (e.g., having 0.1-110%. preferably 1-6%) salidroside by total weight of composition) produced a significant increase in total testosterone as compared to placebo. For example, after taking 2 grams of standardized rhodiola extract with 2% salidroside, once a day for a month, subjects showed about a 76% increase in total testosterone in the blood as compared to the 6.0% increase in total testosterone level after taking placebo for a month. These amounts, however, can be increased by any value, e.g., at least about 5%, 10%, 15%, 20%, 50%, 60% 70%, 75%, 100%, 2-fold, 5-fold, etc., over amounts which are present in the blood prior to administration.
- The present invention also relates to a method of increasing estradiol levels in a host in need thereof, comprising, administering an effective amount of a Rhodiola to said host.
- Estradiol is a female sex hormone that stimulates the appearance of secondary female sex characteristics in girls at puberty. Estradiol controls growth of the lining of the uterus during the first part of the menstrual cycle, cause changes in the breast during pregnancy, and regulate various metabolic processes. Increasing estradiol can treat various conditions, including menopausal symptoms, estrogen deficiencies in women (most commonly after menopause; low eight; etc) and inflammation of the vagina. It can also stimulate lactation following childbirth and in the treatment, but not cure, advanced and even disseminated cancer of the prostate gland in men. Amounts of estradiol can be increased by any value, e.g., 5%, 6%, 8%, 10%, 15%, 20%, 30%, 50%, 75%, 100%, 2-fold, 5-fold, etc., over amounts which are present in the blood prior to administration. For example, in Example 10, Rhodiola as effective in increasing estradiol levels by about 12% as compared to only 3% in controls. Thus, Rhodiola can used to treat conditions associated with estrogen deficiency, such as menopuse, perimenopause, low-weight, etc.
- Rhodiola can be combined with any agent which raises testosterone and/or estradiol levels. For example, testosterone precursors, such as those disclosed in U.S. Pat. Nos. 5,880,117 and 6,011,027, e.g., 4-androstenediol and 19-nor-4-androstenediol, can be utilized in combination with Rhodiola as a means of increasing testosterone levels in human. Currently, 4-androstenedione, 5-androstenedione, 4-androstenediol, 5-androstenediol, 19-nor4-androstenedione, 19-nor-5-androstenedione, 19-nor-4-androstenediol, and 19-nor-5androstenediol, Beta-ecdysterone, and 5-Methyl-7-Methoxy Isoflavone are being used to increase the testosterone level in humans. Rhodiola crenulata can be used with these ingredients to enhance their effects of boosting the testosterone level, other hormones, such as estradiol. Rhodiola crenulata can also be formulated to boost hormonal levels with other herbs, such as wild yam, Epimedium (including all Epimedium species), Angelica, Lycium, panex ginseng, Ganoderma lucidum, Codonopsis, Eleutherococcus, Schisandra chinensis, Atractylodes, and Ligustrum lucidum.
- The present invention also relates methods of improving sleep in a host in need thereof, comprising administering an effective amount of a Rhodiola to said host. By the phrase “improving sleep,” it meant bringing about a beneficial effect on sleep, including, e.g., prolonging sleep time (e.g., as measured in animal models by administering Rhodiola in the presence or absence of a barbiturate, or other sleep-promoting agent, and determining the sleep-prolongation time produced by Rhodiola), increasing time spent in REM-sleep, reducing sleep apnea and other sleep disorders, decreasing insomnia, decreasing amount of time to fall asleep, etc.
- Rhodiola can also be formulated with other agents which promote sleep, such as Valerian, Melatonin, Kava Kava, St. John's Wort, Tryptophan and 5-Hydroxytryptophan, Astragalus, Hops, Passionflower, Skullcap, Chamomile, He Shou Wu, Ashwaganda, and Lady's Slipper.
- The present invention also relates to methods of treating impotence, comprising administering an effective amount of Rhodiola, preferable Rhodiola crenulata. Impotency, or erectile dysfunction, is the inability to achieve an erection. The ability of Rhodiola crenulata to increase the blood oxygen transportation and testosterone level can enhance male sexual ability and performance in some cases. The Rhodiola can be administered immediately prior to performance, or more preferably, on a daily basis according to the regime mentioned above to increase testosterone levels. Rhodiola can also be administered in combination with agents which are used for treating impotency, including, e.g., vasodilators, phosphodiesterase inhibitors, stimulators of NO release, alpha-adrenergic agents, etc.
- Administration of Rhodiola crenulata can also be used to enhance blood oxygen levels and transport to body tissues; to enhance working capacity and endurance. By “working capacity and endurance,” it preferably meant that the effective amount increases the ability to perform a physical task, such as in exercise, physical labor, or sports activity, even before fatigue would normally occur; thus, enhanced working capacity and endurance is defined herein not to mean “fatigue,” which simply indicates that the performer does not tire. Associated with enhanced working capacity and endurance can be an increase in muscle ATP levels and a reduction in circulating lactic acid levels (see, Examples 2 and 3). Thus, the present invention also relates to methods of increasing muscle ATP levels and/or reducing lactic acid in blood, thereby enhancing working capacity and endurance, improving sexual performance, etc.
- As shown in the Example 2, Rhodiola crenulata reduces blood lactic acid (lactate) levels. Such reduction in lactic acid levels indicates that muscle fatigue is reduced. By “muscle fatigue,” it is meant that the muscle cells carry out anaerobic respiration because of lack of oxygen. Reducing muscle fatigue therefore means, e.g., that fewer muscle cells become anaerobic. The present invention therefore also relates to a method of reducing muscle fatigue comprising administering an effective amount of Rhodiola crenulata. Lactic acid can be reduced by an effective amount in ameliorating fatigue, such as at least 10%, 15%,20%,25%,30%,35%, etc.
- As shown in Example 3, Rhodiola crenulata increases the ATP available to muscle, e.g., by increasing aerobic respiration, by increasing oxygen transport, etc. Amounts of ATP can be increased by an effective amount in reducing muscle fatigue, such as 20%, 25%, 30%, 35%, 37%, 40%, 40%, 45%, 50%, etc.
- Rhodiola can also be used to enhance or improved memory and concentration (such improved functions are to be distinguished from the more general brain stimulation which indicates increased non-selective neuronal activity, whereas the mentioned improved functions are selective, e.g., by stimulating specific parts of the brain or other organs, or by stimulating specific neural and hormonal systems); to reduce stress, e.g., lower blood pressure, reduce anxiety, promote calmness; to enhance cardiac and cardiovascular function (including, e.g., to protect against heart disease); to provide antioxidant effects and protect against oxidation; to provide anti-cancer effects, e.g., promote cessation of cell growth; to promote DNA repair; to provide anti-radiation effects and to protect against radiation, e.g., as a sun-screen when applied topically to the skin; to reduce inflammation, e.g., systemic inflammation, skin inflammation (where Rhodiola can be administered topically), but with the proviso that it is not lung-inflammation, coughing, or bleeding associated with lung-inflammation and coughing, to increase insulin, to decrease levels of glucagon, to reduce histamine release, to reduce allergic reactions, to enhance sexual ability. Rhodiola crenulata in accordance with the present invention is preferably not used to treat external wounds, external burns, lung inflammation, and coughing.
- Method of Examples One, Two, and Three
- 20 Kunming-species mice (10 males and 10 females), weighing approximately 18-22 grams each, were randomly divided into experimental and control groups, with each group containing 10 mice. Mice in the experimental group were provided with food containing about 50 mg (0.05 gram, about 0.25 gram every 1 kilogram body weight) Rhodiola crenulata per day for 3 days. Mice in the control group were fed with the same food but without Rhodiola crenulata.
- Example One
- After 3 days of consuming food containing Rhodiola crenulata, the mice were subjected to a swimming test. A lead weight that comprised about 6% of the mice's body weight was attached to each mouse prior to placing it in a water-filled receptacle. The average survival time for experimental group was 92.85±5.20 minutes while for the control group it was 69.89±5.10 minutes. This represents a 33% improvement in the endurance of mice fed Rhodiola crenulata as compared to controls.
- Example Two
- After one hour of swimming, the blood lactate levels were assayed as a measure of fatigue. The average blood lactate level for the experimental group was 14.50±1.41 mmol/L while the control group was 19.30±1.80 mmol/L. Thus, muscle fatigue levels were reduced by 25% in mice fed Rhodiola crenulata.
- Example Three
- After one hour of swimming, the levels of skeletal muscle ATP level were measured. The average skeletal ATP level for the experimental group was 210.45±14.88 mg/100 g while for the control group it was 153.88±20.67 mg/100 g. ATP levels were increased by 37% in mice fed Rhodiola crenulata, indicating that the herb enhanced energy levels.
- Method for Example Four, Five, Six, Seven, Eight, Nine, Ten, Eleven
- 40 volunteers are divided into two groups, each comprising 20 people. The test group was administered 2 grams of Rhodiola crenulata standardized extract (with 2% salidroside), once a day for one month. The control group received a placebo. After one month, each participant was required to assess improvement of their memory, sleep, physical strength, and sexual performance. Blood samples were collected prior to taking any Rhodiola and after the one-month period.
- Example Four
- Using a blood oxygen analyzer, the blood oxygen pressure of each participant before and after taking Rhodiola crenulata extract and placebo was tested. The average of the blood oxygen pressure of the test group before and after taking Rhodiola crenulata for a month was 6.97±0.64 and 7.86±0.90 respectively. For the control group, the average testosterone level before and after taking placebo for a month was 6.87±0.66 and is 7.04±0.95 respectively. These results show after taking Rhodiola crenulata for one month, the oxygen transport and supply in the human body is enhanced by about 12.6%.
- Example Five
- The test subjects were asked whether their memory was improved during the course of the test. In the test group, 45% stated that their memory was improved after one month of the medication. In the control group, only 21% reported memory improvement after one month of the placebo.
- Example Six
- The test subjects were asked whether their physical strength was improved. In the test group, 81% reported improvements in physical strength after one month of the medication as compared to only 38% in the control group.
- Example Seven
- Test subjects were asked whether their sexual performance was improved. In the test group, 75% described improved sexual performance after one month of the Rhodiola extract. In the control group, only 28.9% said their sexual performance was improved.
- Example Eight
- Test subjects were asked whether their sleep is improved. In the test group, 83% of the subjects their sleep was improved after one month of the Rhodiola. In the control group, 41% said their sleep is improved after one month medication.
- Example Nine
- Using an enzyme-linked immunosorbent assay, the blood testosterone levels of each participant was tested. The average of testosterone level of the test group before and after taking Rhodiola crenulata, once a day, for a month was 17.68±5.6 mmol/L and 31.12±10.6 mmol/L, respectively. For the control group, the average testosterone level before and after taking placebo for a month was 18.02±6.0 mmol/L and 19.10±7.6 mmol/L respectively. The Rhodiola increased testosterone levels by 76%, while in controls the increase was only 6%.
- Example Ten
- Using an enzyme-linked immunosorbent assay, the blood estradiol levels of each participant before and after taking Rhodiola crenulata extract and placebo were tested. The average of estradiol level of the test group before and after taking Rhodiola crenulata for a month was 163.56±33.9 mmo/L and 182.93±107.34 mmol/L respectively. For the control group, the average estradiol level before and after taking placebo for a month was 164.5±34.43 mmol/L and 169.30±40.02 mmol/L respectively. Rhodiola increased estradiol levels by about 12% whereas in control the increase was only about 3%.
- Example Eleven
- The blood content of superoxide dismutase (SOD) levels of each participant was tested using the method of pyrogallol auto-oxidization before and after taking Rhodiola crenulata extract and placebo. The average of SOD level of the test group before and after taking Rhodiola crenulata for a month was 1173.8±122.2 U/g.Hb and 1296.7±157.3 U/g.Hb respectively. For the comparison group, the average testosterone level before and after taking placebo for a month was 1173.4±121.5 U/g.Hb and 1205.8±147.40 U/g.Hb respectively. This test indicates that Rhodiola crenulata has antioxidant effects.
- Example Twelve
- A composition comprising effective amounts of Rhodiola crenulata can be administered to subjects to enhance levels of blood oxygen, to enhance working capacity and endurance, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to modulate testosterone levels, to modulate sleep, and to improve sexual performance. to increase energy level, and to enhance memory and concentration. Such a composition can comprise, by weight:
- 60% Rhodiola crenulata, having 2% salidroside content; and
- 30% of a 5:1 extracted fructus lycii powder; and
- 10% of hippophae rhamnoides powder.
- Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preceding preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limiting the remainder of the disclosure in any way whatsoever. The entire disclosure of all applications, patents and publications, cited above and in the figures are hereby incorporated by reference in their entirety.
Claims (29)
1. A method of increasing testosterone levels in a subject in need thereof, comprising, administering an effective amount of a Rhodiola to said subject.
2. A method of claim 1 , with the proviso that said subjects do not have lung inflammation, coughing, or an external wound or burn.
3. A method of claim 1 , wherein said testosterone levels are raised by at least 10%.
4. A method of claim 1 , wherein said testosterone levels are raised by at least 15%.
5. A method of claim 1 , wherein said Rhodiola is Rhodiola crenulata.
6. A method of claim 2 , wherein said Rhodiola is an extract which comprises 2% salidroside by weight.
7. A method of claim 1 , wherein said increase in testosterone level is effective in enhancing sexual performance, maintaining muscle and bone mass, and improving sexual function and psychological well being.
8. A method of treating estrogen deficiency in a female human subject in need thereof, comprising administering an effective amount of Rhodiola to said subject, whereby said amount is effective in increasing blood estradiol levels.
9. A method of claim 8 , with the proviso that said subjects do not have lung inflammation, coughing, or an external wound or burn.
10. A method of claim 8 , wherein said estrodiol levels are increased by at least 10%.
11. A method of claim 9 , wherein said subject is menopausal.
12 A method of improving sleep in a subject in need thereof, comprising, administering an effective amount of a Rhodiola to said subject.
13. A method of claim 12 , with the proviso that said subjects do not have lung inflammation, coughing, or an external wound or burn.
14 A method of claim 13 , wherein said Rhodiola is Rhodiola crenulata.
15. A method of enhancing transport of blood oxygen, enhancing working capacity and endurance, or enhancing cardiac and cardiovascular function in a subject in need thereof, comprising,
administering an effective amount of a Rhodiola crenulata to said subject, whereby said amount of Rhodiola is effective to reduce blood levels of lactate.
16. A method of claim 15 , wherein said amount of Rhodiola is effective to raise skeletal levels of ATP.
17. A method of claim 15 , wherein the skeletal levels of ATP are raised at least 30%.
18. Am method of claim 15 , wherein blood levels of lactate are reduced at least 20%.
19. A method of claim 15 , with the proviso that said subjects do not have lung inflammation, coughing, or an external wound or burn.
20. A method of enhancing memory and concentration in a subject in need thereof, comprising,
administering an effective amount of a Rhodiola crenulata to said subject.
21. A method of claim 20, with the proviso that said subjects do not have lung inflammation, coughing, or an external wound or burn.
administering an effective amount of a Rhodiola crenulata to said subject.
23. A method of claim 20, with the proviso that said subjects are do not have lung inflammation, coughing, or an external wound or burn.
24. A method of claim 22, wherein blood levels of lactate are reduced at least 20%.
25. A method of claim 1 , wherein said composition for increasing hormonal levels of testosterone or estradiol, comprising
an effective amount of Rhodiola crenulata, and
an effective amount of an herb selected from wild yam, Epimedium, Angelica, Lycium, panex ginseng, Ganoderma lucidum, Codonopsis, Eleutherococcus, fructus lycii, hippophae rhamnoides, Schisandra chinensis, Atractylodes, Yohimbe, Tribulus Terrestris, Guggle, Guarana, Cordyceps, Codonopsis, maca, or Ligustrum lucidum.
26. A method of claim 1 , wherein said composition for increasing hormonal levels of testosterone or estradiol, comprising
an effective amount of Rhodiola crenulata, and
an effective amount 4-drostenedione, 5-androstenedione, 4(or 5-)androstenediol, 19nor-4 (or 5-)-drostenedione, 19-nor-4 (or 5-)-androstenediol, Beta-ecdysterone, and 5-Methyl-7-Methoxy Isoflavone.
27. A method of claim 12 , wherein said composition for enhancing sleep, comprising
an effective amount of Rhodiola crenulata, and
an effective amount of an agent selected from Valerian, Melatonina, Kava Kava, St. John's Wort, Trytophan and 5-Hydroxytryptophan, Astragalus, Hops, Passionflower, Skullcap, Chamomile, He Shou Wu, Ashwaganda, fructus lycii, hippophae rhamnoides, or Lady's Slipper.
28. An herbal composition comprising:
an amount of Rhodiola crenulata, and
an amount of a herb selected from pine pollen, fructus lycii, hippophae rhamnoides, Salvia Miltiorrhiza, Ligusticum, Acanthopanax, Astragalus, Ephedra, codonopsis, polygola tenuifolia Willd, Lilium, Guggle, Kudzu, red clover, pine bark extract, St.
John's Wort, Green tea, Yohimbe, Rehmania, Hawthorn, Guarana, Goldenseal, Fo-ti, Ephedra, Dong Quai, Cordyceps, Codonopsis, Citrus Aurantium, Sparganium, ginseng, panax notogiseng, Garcinia, Guggle, Grape Seed Extract or powder, Ginkgo Biloba., Creatine Monohydrate, D-Ribose, Pyruvate, NADH, Co-enzyme Q10, Camitine, or Conjuagated Linoleic Acid.
29. A composition of claim 28, comprising:
20-70% Rhodiola crenulata extract, said extract having 0.5-10% salidroside content,
10-45% 5:1 extracted fructus lycii powder;
1-20% of hippophae rhamnoides powder; and, optionally,
a pharmaceutically-acceptable excipient.
30. An herbal composition of claim 28,
wherein said composition is effective to enhance levels of blood oxygen, to enhance working capacity and endurance, to enhance memory and concentration, to reduce stress, to enhance cardiac and cardiovascular function, to provide antioxidant effects, to modulate testosterone levels, to modulate sleep, to improve sexual performance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/139,383 US20020127285A1 (en) | 2000-04-28 | 2002-05-07 | Rhodiola and uses thereof |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/559,830 US6399116B1 (en) | 2000-04-28 | 2000-04-28 | Rhodiola and used thereof |
| US10/139,383 US20020127285A1 (en) | 2000-04-28 | 2002-05-07 | Rhodiola and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/559,830 Division US6399116B1 (en) | 2000-04-28 | 2000-04-28 | Rhodiola and used thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020127285A1 true US20020127285A1 (en) | 2002-09-12 |
Family
ID=24235199
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/559,830 Expired - Fee Related US6399116B1 (en) | 2000-04-28 | 2000-04-28 | Rhodiola and used thereof |
| US10/139,383 Abandoned US20020127285A1 (en) | 2000-04-28 | 2002-05-07 | Rhodiola and uses thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/559,830 Expired - Fee Related US6399116B1 (en) | 2000-04-28 | 2000-04-28 | Rhodiola and used thereof |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US6399116B1 (en) |
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050002992A1 (en) * | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| US20050031718A1 (en) * | 2003-04-10 | 2005-02-10 | Pharmanex, Llc | Sea Buckthorn compositions and associated methods |
| GB2405335A (en) * | 2003-08-28 | 2005-03-02 | Coletica | Use of Rhodiola crenulata extract via the topical route |
| US20050048136A1 (en) * | 2003-08-27 | 2005-03-03 | Choudhry Muhammad S. | Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness |
| US20050202104A1 (en) * | 2002-09-28 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Method of enhancement of cognitive skills |
| WO2005115426A1 (en) * | 2004-05-31 | 2005-12-08 | Wakunaga Pharmaceutical Co., Ltd. | Drug for ameliorating male climacteric disorder |
| US20060002871A1 (en) * | 2004-06-30 | 2006-01-05 | Goldstein Mindy S | Cosmetic compositions and methods comprising rhodiola rosea |
| US20060198872A1 (en) * | 2005-03-07 | 2006-09-07 | Chioma Ikonte | Plant based dietary supplement for improving the duration and quality of sleep |
| JP2006306889A (en) * | 2004-05-31 | 2006-11-09 | Wakunaga Pharmaceut Co Ltd | Drug for ameliorating male climacteric disorder |
| US20060269623A1 (en) * | 2005-05-31 | 2006-11-30 | Pierre Swaab | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men |
| JP2007084559A (en) * | 2004-05-31 | 2007-04-05 | Wakunaga Pharmaceut Co Ltd | Blood testosterone level-lowering inhibitor |
| US20070196348A1 (en) * | 2006-02-23 | 2007-08-23 | Gardiner Paul T | Compositions and methods for the induction and maintenance of quality sleep |
| KR100848213B1 (en) | 2007-03-23 | 2008-07-24 | 주식회사한국신약 | White Jill Extract with Growth Hormone Promoting Effect |
| WO2008051170A3 (en) * | 2006-10-24 | 2008-09-04 | Vladimir Daniska | Beverage with energizing effects |
| CN100417333C (en) * | 2004-08-12 | 2008-09-10 | 薛惠芳 | A kind of feed additive for preventing laying hens from pecking each other's anus and improving egg production |
| CN100448446C (en) * | 2005-08-16 | 2009-01-07 | 水利部沙棘开发管理中心 | Seabuckthorn extract, its preparation method and its application in the preparation of medicine |
| US20090274783A1 (en) * | 2008-04-17 | 2009-11-05 | Integrated Chinese Medicine Holdings Ltd. | Herbal compositions and methods for enhancing vital energy and athletic performance |
| US20090317497A1 (en) * | 2006-04-20 | 2009-12-24 | Wen Hsien Chou | Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders |
| WO2010140832A3 (en) * | 2009-06-04 | 2011-04-14 | 안국약품 주식회사 | Pharmaceutical composition containing herbal extracts for preventing or treating nephritis |
| US20120128832A1 (en) * | 2010-11-22 | 2012-05-24 | Smith Rogelio A | Organic vegan protein shakes |
| US20120177623A1 (en) * | 2011-01-10 | 2012-07-12 | Morteza Naghavi | Compositions for Boosting Metabolism, Assisting Weight Loss, and Promoting Cardiovascular Health |
| CN102648964A (en) * | 2011-02-28 | 2012-08-29 | 王春玉 | Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease |
| WO2013016636A1 (en) * | 2011-07-27 | 2013-01-31 | Max International, Llc | Compositions comprising sugar-cysteine products |
| CN103110741A (en) * | 2012-12-22 | 2013-05-22 | 潘海燕 | Medicinal liquor for treating stomach illness |
| CN103127276A (en) * | 2011-11-29 | 2013-06-05 | 北京清美联创干细胞科技有限公司 | Anti-aging health care preparation by promoting proliferation and differentiation in stem cells |
| CN103565929A (en) * | 2013-11-21 | 2014-02-12 | 王大娟 | Traditional Chinese medicine combination for treating heart blood deficiency type night sweat |
| CN104224885A (en) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | Traditional Chinese medicine composition for relieving physical fatigue |
| CN104970371A (en) * | 2015-07-02 | 2015-10-14 | 湖南炎帝生物工程有限公司 | Health-care food with antioxidant function |
| US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
| CN107551141A (en) * | 2017-10-24 | 2018-01-09 | 张永 | A kind of Wen Yang consolidates Chinese medicine tea-drinking of resisting cold and preparation method thereof |
| CN107691736A (en) * | 2017-09-29 | 2018-02-16 | 武汉华士特工业生物技术开发有限公司 | A kind of maca pollen grains candy and preparation method thereof |
| US10967024B2 (en) | 2018-09-26 | 2021-04-06 | Aretha Duncan | Synergistic herbal stimulant compositions |
| WO2024118452A1 (en) * | 2022-11-30 | 2024-06-06 | NutriScience Innovations LLC | Rhodiola crenulata compositions and methods of making the same |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6908614B2 (en) * | 1999-10-12 | 2005-06-21 | Chee-Keung Chung | Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| US6485758B2 (en) * | 2000-02-18 | 2002-11-26 | Vasolabs, Inc. | Hangover treatment |
| KR100439209B1 (en) * | 2001-03-30 | 2004-07-07 | 남종현 | Natural tea for improving stamina and preparing method thereof |
| US20030069203A1 (en) * | 2001-06-04 | 2003-04-10 | Lee Steve S. | Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate |
| CN1625406A (en) * | 2001-08-09 | 2005-06-08 | 底古萨食品配料有限公司 | Preparations containing lysophosphatidylserine for the prevention and treatment of stressful states in warm-blooded animals |
| EP1425026B1 (en) * | 2001-09-14 | 2010-05-05 | Max Zeller Söhne AG | Valeriana officinalis extract for treating sleep-induced apnea or hypopnea |
| US6905706B2 (en) * | 2002-04-16 | 2005-06-14 | Swedish Herbal Institute | Medicinal herbal extract carpediol for treating depression |
| ITRM20020620A1 (en) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE. |
| US7776913B2 (en) * | 2002-12-13 | 2010-08-17 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Carnitines for treating or preventing disorders caused by andropause |
| EP1663103B1 (en) * | 2003-09-08 | 2011-11-09 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
| JP2007505934A (en) * | 2003-09-22 | 2007-03-15 | ジェニアス バイオメド インターナショナル インコーポレイテッド | Hippophaerhamnoides composition for cancer treatment |
| US20060024339A1 (en) * | 2004-07-29 | 2006-02-02 | Howard Murad | Methods of managing the redness associated with a dermatological condition |
| ES2702047T3 (en) * | 2004-11-16 | 2019-02-27 | Dsm Ip Assets Bv | Use of antioxidant compounds for muscle damage |
| WO2006122274A2 (en) * | 2005-05-11 | 2006-11-16 | Baystate Health Systems, Inc. | Pharmaceutical formulations of rhodiola crenulata and methods of use thereof |
| TR201902588T4 (en) * | 2006-10-05 | 2019-03-21 | Dsm Ip Assets Bv | The use of hydroxytyrosol to reduce the amount of lactic acid in plasma. |
| US20110117121A1 (en) * | 2006-10-27 | 2011-05-19 | James Dao | Compositions for treatment and inhibition of pain |
| US7794758B2 (en) * | 2007-04-05 | 2010-09-14 | Pmc Formulas, Inc. | Compounds and methods for promoting cellular health and treatment of cancer |
| US8394425B2 (en) * | 2007-04-05 | 2013-03-12 | Pmc Formulas, Inc. | Methods for promoting cellular health and treatment of cancer |
| US20110097427A1 (en) * | 2009-10-27 | 2011-04-28 | Shyam Ramakrishnan | Molecular Targets and Dietary Modulators of Exercise-Induced Muscle Damage |
| SG10201606987YA (en) | 2011-09-06 | 2016-10-28 | Billion King Int Ltd | Oral delivery for hemoglobin based oxygen carriers |
| US9763889B2 (en) | 2015-06-29 | 2017-09-19 | Billion King International Ltd. | Oral delivery system for hemoglobin based oxygen carriers |
| US10052290B2 (en) | 2016-02-04 | 2018-08-21 | Billion King International Ltd. | Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers |
| CN110643582B (en) * | 2019-09-29 | 2021-07-27 | 浙江工业大学 | A kind of method for extracting SOD from fresh sea buckthorn fruit |
| EP4366730A4 (en) | 2021-07-05 | 2025-06-04 | Celesta Company LLC | COMPOSITION FOR PROMOTING RESTFUL SLEEP AND METHODS OF MAKING AND USING THE SAME |
| CN116139157B (en) * | 2023-04-19 | 2023-07-04 | 中国农业大学 | Application of salidroside in promoting growth and development of ovarian follicles and preparing ovulation promoting medicine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138984A (en) * | 1995-06-26 | 1997-01-01 | 军事医学科学院放射医学研究所 | Anti-thrombosis glucoside medicine |
-
2000
- 2000-04-28 US US09/559,830 patent/US6399116B1/en not_active Expired - Fee Related
-
2002
- 2002-05-07 US US10/139,383 patent/US20020127285A1/en not_active Abandoned
Cited By (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202104A1 (en) * | 2002-09-28 | 2005-09-15 | Boehringer Ingelheim International Gmbh | Method of enhancement of cognitive skills |
| US20050031718A1 (en) * | 2003-04-10 | 2005-02-10 | Pharmanex, Llc | Sea Buckthorn compositions and associated methods |
| US20060263459A1 (en) * | 2003-04-10 | 2006-11-23 | Pharmanex, Llc | Sea Buckthorn Compositions and Associated Methods |
| US20050002992A1 (en) * | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| US20050048136A1 (en) * | 2003-08-27 | 2005-03-03 | Choudhry Muhammad S. | Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness |
| FR2859102A1 (en) * | 2003-08-28 | 2005-03-04 | Coletica | USE OF A RHODIOLA CRENULATA EXTRACT BY TOPIC |
| US20050048138A1 (en) * | 2003-08-28 | 2005-03-03 | Coletica | Use of Rhodiola crenulata extract via the topical route |
| GB2405335B (en) * | 2003-08-28 | 2006-03-08 | Coletica | Use of rhodiola crenulata extract via the topical route |
| GB2405335A (en) * | 2003-08-28 | 2005-03-02 | Coletica | Use of Rhodiola crenulata extract via the topical route |
| US20120107425A1 (en) * | 2003-08-28 | 2012-05-03 | Eric Perrier | Use of rhodiola crenulata extract via the topical route |
| WO2005115426A1 (en) * | 2004-05-31 | 2005-12-08 | Wakunaga Pharmaceutical Co., Ltd. | Drug for ameliorating male climacteric disorder |
| JP2007084559A (en) * | 2004-05-31 | 2007-04-05 | Wakunaga Pharmaceut Co Ltd | Blood testosterone level-lowering inhibitor |
| US20080274213A1 (en) * | 2004-05-31 | 2008-11-06 | Wakunaga Pharmaceutical Co., Ltd. | Drug for Ameliorating Male Climacteric Disorders |
| JP2006306889A (en) * | 2004-05-31 | 2006-11-09 | Wakunaga Pharmaceut Co Ltd | Drug for ameliorating male climacteric disorder |
| US20080268074A1 (en) * | 2004-06-30 | 2008-10-30 | Goldstein Mindy S | Cosmetic Compositions and Methods Comprising Rhodiola Rosea |
| US20100297042A1 (en) * | 2004-06-30 | 2010-11-25 | Goldstein Mindy S | Cosmetic Compositions and Methods Comprising Rhodiola Rosea |
| US20060002871A1 (en) * | 2004-06-30 | 2006-01-05 | Goldstein Mindy S | Cosmetic compositions and methods comprising rhodiola rosea |
| US7449203B2 (en) | 2004-06-30 | 2008-11-11 | E-L Management Corporation | Cosmetic compositions and methods comprising Rhodiola rosea |
| CN100417333C (en) * | 2004-08-12 | 2008-09-10 | 薛惠芳 | A kind of feed additive for preventing laying hens from pecking each other's anus and improving egg production |
| US20060275520A1 (en) * | 2005-03-07 | 2006-12-07 | Access Business Group International Llc | White peony extract for improving the duration and quality of sleep |
| US20060198872A1 (en) * | 2005-03-07 | 2006-09-07 | Chioma Ikonte | Plant based dietary supplement for improving the duration and quality of sleep |
| US20060269623A1 (en) * | 2005-05-31 | 2006-11-30 | Pierre Swaab | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men |
| CN100448446C (en) * | 2005-08-16 | 2009-01-07 | 水利部沙棘开发管理中心 | Seabuckthorn extract, its preparation method and its application in the preparation of medicine |
| US7914826B2 (en) * | 2006-02-23 | 2011-03-29 | Iomedix Sleep International Srl | Method for promoting sleep |
| US20070264337A1 (en) * | 2006-02-23 | 2007-11-15 | Gardiner Paul T | Compositions and methods for the induction and maintenance of quality sleep |
| US20090011015A1 (en) * | 2006-02-23 | 2009-01-08 | Iomedix Sleep International | Method for promoting sleep |
| US7476405B2 (en) * | 2006-02-23 | 2009-01-13 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
| US7906154B2 (en) * | 2006-02-23 | 2011-03-15 | Heuer Marvin A | Compositions and methods for the induction and maintenance of quality sleep |
| US20070196348A1 (en) * | 2006-02-23 | 2007-08-23 | Gardiner Paul T | Compositions and methods for the induction and maintenance of quality sleep |
| US20090317497A1 (en) * | 2006-04-20 | 2009-12-24 | Wen Hsien Chou | Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders |
| US20100062112A1 (en) * | 2006-10-24 | 2010-03-11 | Daniska Vladimir | Beverage with energizing effects |
| WO2008051170A3 (en) * | 2006-10-24 | 2008-09-04 | Vladimir Daniska | Beverage with energizing effects |
| KR100848213B1 (en) | 2007-03-23 | 2008-07-24 | 주식회사한국신약 | White Jill Extract with Growth Hormone Promoting Effect |
| US7906159B2 (en) * | 2008-04-17 | 2011-03-15 | Vivien Chou | Herbal compositions and methods for enhancing vital energy and athletic performance |
| US20090274783A1 (en) * | 2008-04-17 | 2009-11-05 | Integrated Chinese Medicine Holdings Ltd. | Herbal compositions and methods for enhancing vital energy and athletic performance |
| US20110091585A1 (en) * | 2008-04-17 | 2011-04-21 | Integrated Chinese Medicine Holdings Ltd. | Herbal compositions and methods for enhancing vital energy and athletic performance |
| US8119170B2 (en) * | 2008-04-17 | 2012-02-21 | Wen Hsien Chou | Herbal compositions and methods for enhancing vital energy and athletic performance |
| CN102497874B (en) * | 2009-06-04 | 2014-07-30 | 韩国安国药品株式会社 | Pharmaceutical composition containing medicinal herb extract for preventing or treating nephritis |
| CN102497874A (en) * | 2009-06-04 | 2012-06-13 | 韩国安国药品株式会社 | Pharmaceutical composition containing medicinal herb extract for preventing or treating nephritis |
| WO2010140832A3 (en) * | 2009-06-04 | 2011-04-14 | 안국약품 주식회사 | Pharmaceutical composition containing herbal extracts for preventing or treating nephritis |
| US8642096B2 (en) | 2009-06-04 | 2014-02-04 | Ahn-Gook Pharmaceutical Co., Ltd. | Pharmaceutical composition containing herbal extract for prevention or treatment of nephritis |
| US20120128832A1 (en) * | 2010-11-22 | 2012-05-24 | Smith Rogelio A | Organic vegan protein shakes |
| US20120177623A1 (en) * | 2011-01-10 | 2012-07-12 | Morteza Naghavi | Compositions for Boosting Metabolism, Assisting Weight Loss, and Promoting Cardiovascular Health |
| US8815310B2 (en) * | 2011-01-10 | 2014-08-26 | Morteza Naghavi | Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health |
| CN102648964A (en) * | 2011-02-28 | 2012-08-29 | 王春玉 | Medicine for treating headache, hypertension and cardiovascular and cerebrovascular disease |
| WO2013016636A1 (en) * | 2011-07-27 | 2013-01-31 | Max International, Llc | Compositions comprising sugar-cysteine products |
| CN103127276A (en) * | 2011-11-29 | 2013-06-05 | 北京清美联创干细胞科技有限公司 | Anti-aging health care preparation by promoting proliferation and differentiation in stem cells |
| CN103110741A (en) * | 2012-12-22 | 2013-05-22 | 潘海燕 | Medicinal liquor for treating stomach illness |
| CN103565929A (en) * | 2013-11-21 | 2014-02-12 | 王大娟 | Traditional Chinese medicine combination for treating heart blood deficiency type night sweat |
| CN104224885A (en) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | Traditional Chinese medicine composition for relieving physical fatigue |
| US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
| CN107624069A (en) * | 2015-02-03 | 2018-01-23 | 纳图瑞克斯有限公司 | Compositions and methods for improving muscle metabolism |
| CN104970371A (en) * | 2015-07-02 | 2015-10-14 | 湖南炎帝生物工程有限公司 | Health-care food with antioxidant function |
| CN107691736A (en) * | 2017-09-29 | 2018-02-16 | 武汉华士特工业生物技术开发有限公司 | A kind of maca pollen grains candy and preparation method thereof |
| CN107551141A (en) * | 2017-10-24 | 2018-01-09 | 张永 | A kind of Wen Yang consolidates Chinese medicine tea-drinking of resisting cold and preparation method thereof |
| US10967024B2 (en) | 2018-09-26 | 2021-04-06 | Aretha Duncan | Synergistic herbal stimulant compositions |
| WO2024118452A1 (en) * | 2022-11-30 | 2024-06-06 | NutriScience Innovations LLC | Rhodiola crenulata compositions and methods of making the same |
Also Published As
| Publication number | Publication date |
|---|---|
| US6399116B1 (en) | 2002-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6399116B1 (en) | Rhodiola and used thereof | |
| US6277396B1 (en) | Dietary supplement containing a thermogenic substance and an adrenal support substance | |
| US20210220422A1 (en) | Dietary supplement compositions and methods | |
| US20120141601A1 (en) | Dietary supplement, feed and pharmaceutical composition containing chia seed and maca, and preparation method thereof | |
| US20010006983A1 (en) | Multicomponent biological vehicle | |
| CN101559168B (en) | A pharmaceutical composition for nourishing qi and blood, nourishing liver and kidney, its preparation method and application | |
| CN102697035A (en) | Cordyceps anti-aging pellet | |
| CN104352552B (en) | A kind of food, health products or pharmaceutical composition | |
| Al-Mashhadani et al. | Effect of supplementing different levels of chamomile oil on broiler performance and some physiological traits | |
| US20110189319A1 (en) | Lifeforce liquid supplement | |
| Pundkar et al. | A review: Herbal therapy used in hair loss | |
| CN100544605C (en) | Health-preserving and liver-protecting tea and preparation method thereof | |
| US7338672B2 (en) | Herbal supplement for cognitive related impairment due to estrogen loss | |
| US20070184127A1 (en) | Herbal compositions comprising Portaluca | |
| CN108514114A (en) | Composition for relieving physical fatigue and purposes based on chondriosome nutrient theory | |
| CN112843154A (en) | Blood-enriching hair-growing composition | |
| CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
| CN104940241B (en) | A kind of selenium worm grass compound preparation of prevention climacteric metancholia of women | |
| CN106692532A (en) | Traditional Chinese medicine composition used for burning fat and losing weight as well as patch and weight losing package thereof | |
| CN104095992B (en) | A kind of composition of energy permanent tooth strengthening the bones and muscles and anti-aging of being healthy and strong and preparation method and application | |
| US20060269623A1 (en) | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men | |
| CN101889683A (en) | A kind of health food with anti-fatigue function and preparation method thereof | |
| CN101933968A (en) | Pharmaceutical composition with functions of resisting oxidation and delaying senility and preparation method thereof | |
| Carnevale et al. | Griffonia simplicifolia negatively affects sexual behavior in female rats | |
| CN105412265A (en) | Cat's claw extract and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |